Literature DB >> 913921

Biological activity of synthetic human insulin.

F Märki, W Albrecht.   

Abstract

The biological activity of human insulin, prepared by total chemical synthesis, was compared in various tests in vivo and in vitro with that of natural human or pork insulin. The potencies of the synthetic and natural hormone, as determined by the mouse convulsion assay, by hypoglycaemic effect and diaphragm glycogen increase in fasted rats in vivo, or by stimulation of 14C-glucose metabolism in fat cells and binding to anti-insulin serum in vitro, did not differ significantly. It is concluded that this synthetic human insulin is biologically equivalent to the natural hormone.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 913921     DOI: 10.1007/bf01223268

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  12 in total

1.  [Selective cleavage of peptides in trifluoroethanol with acid-labile amino-protecting groups].

Authors:  B Riniker; B Kamber; P Sieber
Journal:  Helv Chim Acta       Date:  1975-06-04       Impact factor: 2.164

2.  THE ISOLATION AND CRYSTALLIZATION OF HUMAN INSULIN.

Authors:  I A MIRSKY; R JINKS; G PERISUTTI
Journal:  J Clin Invest       Date:  1963-12       Impact factor: 14.808

3.  The estimation of glycogen with the anthrone reagent.

Authors:  S SEIFTER; S DAYTON
Journal:  Arch Biochem       Date:  1950-01

4.  A new semisynthesis of human insulin.

Authors:  R Obermeier; R Geiger
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1976-06

5.  [Total synthesis of human insulin under directed formation of the disulfide bonds].

Authors:  P Sieber; B Kamber; A Hartmann; A Jöhl; B Riniker; W Rittel
Journal:  Helv Chim Acta       Date:  1974       Impact factor: 2.164

6.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

7.  A method for the isolation of insulin from single human pancreas.

Authors:  D Shapcott; D O'Brien
Journal:  Diabetes       Date:  1970-11       Impact factor: 9.461

8.  [Total synthesis of human insulin. IV. Description of the final steps (author's transl)].

Authors:  P Sieber; B Kamber; A Hartmann; A Jöhl; B Riniker; W Rittel
Journal:  Helv Chim Acta       Date:  1977-01-26       Impact factor: 2.164

9.  The Fourth International Standard for insulin.

Authors:  D R BANGHAM; M V MUSSETT
Journal:  Bull World Health Organ       Date:  1959       Impact factor: 9.408

10.  Human crystalline insulin from non-diabetic and diabetic patients.

Authors:  K Brunfeldt; T Deckert; J Thomsen
Journal:  Acta Endocrinol (Copenh)       Date:  1969-03
View more
  5 in total

Review 1.  New approaches to therapy and diagnosis of diabetes.

Authors:  B Hansen; A Lernmark; J H Nielsen; D Owerbach; B Welinder
Journal:  Diabetologia       Date:  1982-02       Impact factor: 10.122

Review 2.  The new insulins. Their characteristics and clinical indications.

Authors:  P D Home; K G Alberti
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

Review 3.  The evolution of insulin glargine and its continuing contribution to diabetes care.

Authors:  Rolf Hilgenfeld; Gerhard Seipke; Harald Berchtold; David R Owens
Journal:  Drugs       Date:  2014-06       Impact factor: 9.546

Review 4.  Bioactive Agent Discovery from the Natural Compounds for the Treatment of Type 2 Diabetes Rat Model.

Authors:  Shih-Chun Yang; Ching-Yun Hsu; Wei-Ling Chou; Jia-You Fang; Shih-Yi Chuang
Journal:  Molecules       Date:  2020-12-03       Impact factor: 4.411

5.  Oral glutamine is superior than oral glucose to promote glycemia recovery in mice submitted to insulin-induced hypoglycemia.

Authors:  Amanda Nunes Santiago; Vilma Aparecida Ferreira de Godoi-Gazola; Mariana Fachin Milani; Vanessa Cristina de Campos; Vanessa Rodrigues Vilela; Maria Montserrat Diaz Pedrosa; Roberto Barbosa Bazotte
Journal:  Int J Endocrinol       Date:  2013-08-24       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.